H103 - 2022 Appropriations Act. (SL 2022-74)

Overview: Section 9F.1 of S.L. 2022-74 amends Section 9F.1 of S.L. 2021-180 (2021 Appropriations Act), which established the Opioid Abatement Reserve, to allow the reserve to maintain funds received by the State as a beneficiary of bankruptcy proceedings relating to claims regarding the manufacturing, marketing, distribution, dispensing, or sale of opioids. It also directs the State Controller to disburse funds from the Opioid Abatement Reserve to be allocated as outlined below.

• $9,225,000 to the Department of Health and Human Services, to be allocated as follows:
• $1,850,000 to the Division of Mental Health, Developmental Disabilities, and Substance Abuse Services for the Prescription Digital Therapeutics Pilot Program.
• $1,000,000 to Triangle Residential Options for Substance Abusers, Inc. to fund the construction of additional units of housing on its Durham campus to provide housing support to individuals in recovery from opioid use disorder.
• $6,000,000 to be allocated equally among the local management entities/managed care organizations (LME/MCOs) to support opioid remediation programs throughout the State.
• $375,000 to the North Carolina Association of County Commissioners to facilitate local and regional strategic planning to maximize the long-term positive impact of the opioid settlement funds received by the State and to satisfy all requirements of the Memorandum of Agreement governing the use of opioid settlement funds by counties and municipalities in North Carolina.
• $5,556,203 to the Board of Governors of The University of North Carolina to be allocated to the University of North Carolina at Chapel Hill for the North Carolina Collaboratory to be used as follows:
• $400,000 to the University of North Carolina Injury Prevention Research Center to expand and operate the Community Opioid Resources Engine for North Carolina.
• $600,000 to support opioid remediation project management and community partnership outreach at North Carolina Central University.
• $1,900,000 to make grants available on a competitive basis to each campus of the constituent institutions of The University of North Carolina for opioid abatement research and development projects.
• $2,656,203 to fund a research partnership concerning opioid abatement with the Eshelman Institute for Innovation at the University of North Carolina at Chapel Hill School of Pharmacy.

This section became effective July 1, 2022.